Alk-Abello AS (CHIX:ALKBC) Other Current Receivables: kr132 Mil (As of Mar. 2026)


CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
93 GF Score
Price kr256.30
GF Value kr207.61
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alk-Abello AS Other Current Receivables?

Alk-Abello AS CHIX:ALKBC 93 Other Current Receivables is kr132 Mil as of Mar. 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 93/100 and a GF Value™ of kr207.61 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Alk-Abello AS's Other Current Receivables for the quarter that ended in Mar. 2026 was kr132 Mil.

Alk-Abello AS's quarterly Other Current Receivables increased from Sep. 2025 (kr48.00 Mil) to Dec. 2025 (kr238.00 Mil) but then stayed the same from Dec. 2025 (kr238.00 Mil) to Mar. 2026 (kr132.00 Mil).

Alk-Abello AS's annual Other Current Receivables declined from Dec. 2023 (kr74.00 Mil) to Dec. 2024 (kr49.00 Mil) but then increased from Dec. 2024 (kr49.00 Mil) to Dec. 2025 (kr238.00 Mil).

Alk-Abello AS Other Current Receivables Related Terms

Alk-Abello AS Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Other Current Receivables Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.00 100.00 74.00 49.00 238.00

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.00 103.00 48.00 238.00 132.00
CHIX:ALKBC
93GF Score
Alk-Abello AS CHIX:ALKBC
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr132 Mil mean?
Alk-Abello AS (CHIX:ALKBC) has a Other Current Receivables of kr132 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Other Current Receivables too high?
Alk-Abello AS's current Other Current Receivables is kr132 Mil. Overall, Alk-Abello AS has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Other Current Receivables compare to VRTX and REGN?
Alk-Abello AS's Other Current Receivables of kr132 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Other Current Receivables is kr132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr207.61, compared to a current price of kr256.30 — trading 23.5% above its estimated fair value. The current Other Current Receivables is kr132 Mil. Alk-Abello AS's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Other Current Receivables is kr132 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 23.5% above its estimated GF Value™ of kr207.61. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • Other Current Receivables: kr132 Mil
  • GF Value™: kr207.61 vs. price of kr256.30 (23.5% above fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
93GF Score

Get the complete analysis for CHIX:ALKBC

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr207.61
GF Value